Paliperidone

Paliperidone
Product Description

Paliperidone Extended-Release (ER) Tablets (available in 1.5 mg, 3 mg, 6 mg, 9 mg, and 12 mg strengths) are high-potency, second-generation (atypical) oral antipsychotic medications. They are prescribed for the acute and maintenance management of psychiatric conditions by stabilizing dopamine and serotonin neurotransmitter pathways in the brain.

Swiftmed International Private Limited

  • Country/Region:
    India
  • On CPHI since:
    2026
  • Certificates:
    3
  • Employees:
    100 - 249
Company types
Pharmaceutical company
Primary activities
Pharmaceutical Company (generic finished products)
Specifications
  • Details
    Benzisoxazole atypical antipsychotic / Dopamine D₂ and Serotonin \(5\text{-HT}_{2A}\) receptor antagonist.Pharmaceutical Delivery System: Formulated using an Osmotic Controlled-Release Oral Delivery System (OROS). The tablet has an osmotic push compartment and a laser-drilled orifice that uses osmotic pressure to release the drug at a controlled, constant rate over 24 hours.Packaging Configurations: Typically packed in high-density polyethylene (HDPE) bottles or calendar blister strips of 28 or 30 tablets to support strict daily adherence tracking.

    Primary Clinical IndicationsSchizophrenia: Treats acute exacerbations and maintains long-term stabilization of schizophrenia in both adults and adolescents (aged 12 to 17 years).Schizoaffective Disorder: Managed as monotherapy or as an adjunct to mood stabilizers/antidepressants to treat the combined psychotic and mood symptoms of schizoaffective disorder in adults.

Swiftmed International Private Limited

  • Country/Region:
    India
  • On CPHI since:
    2026
  • Certificates:
    3
  • Employees:
    100 - 249
Company types
Pharmaceutical company
Primary activities
Pharmaceutical Company (generic finished products)

More Products from Swiftmed International Private Limited (68)

  • Ketamine Hydrochloride Injection

    Product Ketamine Hydrochloride Injection

    Ketamine Hydrochloride Injection USP 50 mg/mL is a sterile, non-pyrogenic aqueous solution containing ketamine hydrochloride, a rapid-acting dissociative anesthetic indicated for the induction and maintenance of general anesthesia. It produces profound analgesia, sedation, and amnesia while generally prese...
  • Large Volume Parentrals

    Product Large Volume Parentrals

    26 Mannitol Injection 20% w/v 27 Mannitol with Glycerine Injection 10% & 10% w/v 28 Metronidazole Injection USP 29 Metronidazole with Dextrose Injection 0.2% & 5.0% w/v 30 Moxifloxacin Injection 0.4% w/v 31 Multiple Electrolytes & Dextrose Injection Type - I / III / IV / V 32 Ornidazole I...
  • Lidocaine + Benzethonium Chloride Spray 50g/75g

    Product Lidocaine + Benzethonium Chloride Spray 50g/75g

    Lidocaine and Benzethonium Chloride Topical Spray is a dual-action, fast-acting first-aid formulation designed to provide immediate temporary pain relief while disinfecting superficial skin injuries. Combining a membrane-stabilizing local anesthetic with a broad-spectrum antiseptic, this aerosol or pump-ac...
  • Lidocaine 5% transdermal patch

    Product Lidocaine 5% transdermal patch

    Lidocaine 5% transdermal patches are prescription-strength, localized topical analgesics engineered to treat peripherally generated neuropathic pain. Unlike oral pain medications, these adhesive patches deliver targeted therapy directly through the skin, desensitizing hyperactive nerve pathways while keepi...
  • Micafungin Injection

    Product Micafungin Injection

    Micafungin for Injection (50 mg and 100 mg strengths) is a prescription-strength, intravenous echinocandin antifungal agent formulated to treat severe, systemic fungal infections. Instead of traditional liquid formats, it is supplied as a sterile, preservative-free lyophilized (freeze-dried) powder cake in...
  • Orforglipron Tablet

    Product Orforglipron Tablet

    Orforglipron Tablet is an oral, small-molecule, non-peptide Glucagon-Like Peptide-1 (GLP-1) receptor agonist designed for daily administration. It is developed to support chronic weight management and improve glycemic control in patients with metabolic conditions. Other Peptides: Tirzepatide Semag...
  • Research Peptides

    Product Research Peptides

    Our peptide portfolio includes custom and catalog peptides manufactured with a focus on quality, purity, and analytical characterization. Products are supplied with appropriate documentation to support laboratory research and development activities, including peptide discovery, assay development, and precl...
  • Rifampicin + Isoniazid

    Product Rifampicin + Isoniazid

    Rifampicin + Isoniazid Tablets 150 mg/150 mg are a fixed-dose combination (FDC) antitubercular medicine containing two first-line anti-tuberculosis agents: Rifampicin 150 mg and Isoniazid 150 mg. The combination is formulated to provide effective bactericidal activity against Mycobacterium tuberculosis whi...
  • Rifaximin

    Product Rifaximin

    Rifaximin 100 mg/5 ml Oral Suspension is a non-systemic, gastrointestinal-targeted antibiotic formulated to treat bacterial infections of the digestive tract. Unlike conventional antibiotics that enter the bloodstream, this oral liquid acts locally inside the intestines. It provides targeted therapy agains...
  • Rivaroxaban

    Product Rivaroxaban

    Rivaroxaban Oral Tablets are high-potency, direct-acting oral anticoagulants (DOACs) prescribed to prevent and treat serious blood-clotting disorders. As a highly selective inhibitor of clotting Factor Xa, this medication helps maintain smooth blood flow without requiring the constant blood monitoring rout...
  • Semaglutide for Injection

    Product Semaglutide for Injection

    Semaglutide for Injection (Prefill Syringe, Single Dose Pen, Multi Dose Pen) available in 0.25mg/0.5mg/1mg/1.7mg/2.4mg strengths. Available with CTD dossier modules 1 to 4 and clinical trial underway. Product is available from a WHO GMP certified plant and available for registration and direct supply to te...
  • Sofosbuvir

    Product Sofosbuvir

    Sofosbuvir 400 mg Tablets are high-potency, direct-acting antiviral (DAA) oral medications prescribed to treat chronic Hepatitis C Virus (HCV) infections. As a foundational nucleotide analog polymerase inhibitor, it blocks viral replication across multiple genotypes of the virus, typically yielding high cu...